HeartBeam, Inc.(BEAT)

Medical - Specialties · Santa Clara, CA

$0.60-0.05 (-7.98%)

Delayed quote: Oct 6, 2026, 9:35 AM EDT

HeartBeam (BEAT) PE Ratio: History & Chart | TGMCharts

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T13:35:43.532Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:35:43.532Z.

Quote observation: 2026-10-06T13:35:08.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.602
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.52

FMP input reference: a5ea7848df566bb1fba137e14a23bd7a424b67da13a14cf2752e181034030ce3

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

BEAT PE Ratio Metrics

PE RATIO

N/A

BEAT Competitors' PE Ratio

BEAT

HeartBeam, Inc.

Current

Market Cap

$33.42M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs BEAT

Market Cap

$34.18M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALGS

Aligos Therapeutics, Inc.

vs BEAT

Market Cap

$34.65M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELUT

Elutia Inc

vs BEAT

Market Cap

$35.68M

PE Ratio

0.86

TTM Avg

1.13

3Y Avg

1.13

5Y Avg

1.13

ELTX

Elicio Therapeutics, Inc.

vs BEAT

Market Cap

$37.37M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARAY

Accuray Incorporated

vs BEAT

Market Cap

$37.13M

PE Ratio

N/A

TTM Avg

241.49

3Y Avg

241.49

5Y Avg

115.68

BCTX

BriaCell Therapeutics Corp.

vs BEAT

Market Cap

$36.45M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs BEAT

Market Cap

$32.55M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCGO

DocGo Inc.

vs BEAT

Market Cap

$36.08M

PE Ratio

N/A

TTM Avg

14.70

3Y Avg

37.22

5Y Avg

37.36

EDSA

Edesa Biotech, Inc.

vs BEAT

Market Cap

$38.53M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
HeartBeam, Inc. (BEAT)	$33.42M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$34.18M	N/A	N/A	N/A	N/A
Aligos Therapeutics, Inc. (ALGS)vs ›	$34.65M	N/A	N/A	N/A	N/A
Elutia Inc (ELUT)vs ›	$35.68M	0.86	1.13	1.13	1.13
Elicio Therapeutics, Inc. (ELTX)vs ›	$37.37M	N/A	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$37.13M	N/A	241.49	241.49	115.68
BriaCell Therapeutics Corp. (BCTX)vs ›	$36.45M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$32.55M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$36.08M	N/A	14.70	37.22	37.36
Edesa Biotech, Inc. (EDSA)vs ›	$38.53M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.60

Forward EPS (Est.)

$-0.38

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

BEAT PE Ratio Metrics

BEAT Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics